BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27148487)

  • 1. Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells.
    Cipolleschi MG; Marzi I; Rovida E; Dello Sbarba P
    Front Oncol; 2016; 6():95. PubMed ID: 27148487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.
    Rovida E; Marzi I; Cipolleschi MG; Dello Sbarba P
    Hypoxia (Auckl); 2014; 2():1-10. PubMed ID: 27774462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.
    Dello Sbarba P; Cheloni G
    Adv Exp Med Biol; 2019; 1143():129-145. PubMed ID: 31338818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.
    Cheloni G; Poteti M; Bono S; Masala E; Mazure NM; Rovida E; Lulli M; Dello Sbarba P
    Stem Cells Int; 2017; 2017():4979474. PubMed ID: 29118813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed lineage leukemia translocations and a leukemia stem cell program.
    Faber J; Armstrong SA
    Cancer Res; 2007 Sep; 67(18):8425-8. PubMed ID: 17875678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia as a biomarker for radioresistant cancer stem cells.
    Peitzsch C; Perrin R; Hill RP; Dubrovska A; Kurth I
    Int J Radiat Biol; 2014 Aug; 90(8):636-52. PubMed ID: 24844374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells niche: a target for novel cancer therapeutics.
    Yi SY; Hao YB; Nan KJ; Fan TL
    Cancer Treat Rev; 2013 May; 39(3):290-6. PubMed ID: 23219150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labeling Cancer Stem Cells with
    Kesh K; Banerjee S
    Methods Mol Biol; 2019; 1996():207-216. PubMed ID: 31127559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche.
    Vander Linden C; Corbet C
    Front Oncol; 2019; 9():159. PubMed ID: 30941310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
    Saijo A; Goto H; Nakano M; Mitsuhashi A; Aono Y; Hanibuchi M; Ogawa H; Uehara H; Kondo K; Nishioka Y
    Cancer Lett; 2018 May; 421():17-27. PubMed ID: 29448000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell niche: the place to be.
    Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
    Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
    Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
    Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Liu C; Liu L; Chen X; Cheng J; Zhang H; Zhang C; Shan J; Shen J; Qian C
    Cancer Res; 2018 Feb; 78(4):938-949. PubMed ID: 29259010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.